Search Results - "Dillon, M.T."

Selective Targeting of the G2/M Cell Cycle Checkpoint to Improve the Therapeutic Index of Radiotherapy by Dillon, M.T, Good, J.S, Harrington, K.J

“…Abstract Despite tremendous advances in radiotherapy techniques, allowing dose escalation to tumour tissues and sparing of organs at risk, cure rates from…”
Get full text

PATRIOT: A phase I study to assess the tolerability, safety and biological effects of a specific ataxia telangiectasia and Rad3-related (ATR) inhibitor (AZD6738) as a single agent and in combination with palliative radiation therapy in patients with solid tumours by Dillon, M.T., Boylan, Z., Smith, D., Guevara, J., Mohammed, K., Peckitt, C., Saunders, M., Banerji, U., Clack, G., Smith, S.A., Spicer, J.F., Forster, M.D., Harrington, K.J.

“…•Summary of a protocol for a phase I study combining the ATR inhibitor and palliative radiotherapy.•Study design is discussed.•Study aims and objectives, brief…”
Get full text

Residual Cochlear Function in Adults and Children Receiving Cochlear Implants: Correlations With Speech Perception Outcomes by Fontenot, Tatyana Elizabeth, Giardina, Christopher Kenneth, Dillon, Megan T., Rooth, Meredith A., Teagle, Holly F., Park, Lisa R., Brown, Kevin David, Adunka, Oliver F., Buchman, Craig A., Pillsbury, Harold C., Fitzpatrick, Douglas C.

“…OBJECTIVES:Variability in speech perception outcomes with cochlear implants remains largely unexplained. Recently, electrocochleography, or measurements of…”
Get full text

ATR inhibition with radiation creates an inflammatory tumour microenvironment by Dillon, M.T., Bergerhoff, K., Pedersen, M., Whittock, H., Patin, E., Smith, H., Paget, J., Patel, R., Bozhanova, G., Foo, S., Campbell, J., Ragulan, C., Fontana, E., Wilkins, A., Sadanandam, A., Melcher, A., McLaughlin, M., Harrington, K.J.

Get full text